The two companies have been battling for years over patents for migraine headache drugs—Emgality for Lilly and Anjovy for Teva. Both drugs are once-monthly injections and were approved 13 days apart in September 2018.
Indiana Attorney General Todd Rokita said he will appeal a Marion County judge’s ruling that grants Indianapolis Public Schools an exemption from state law requiring districts to sell closed school buildings to charter schools for $1.
The federal lawsuit alleges Indianapolis Animal Care Services violated the volunteers’ First Amendment rights when they received threats of termination for wanting to speak publicly about issues plaguing the shelter.
Amazon is accused of violating federal and state antitrust laws, but the company has responded with a full-throated defense of its business practices.
The Satanic Temple filed a federal lawsuit last year, claiming that the new abortion ban violates Indiana’s Religious Freedom Restoration Act.
Dozens of states, including Indiana, are suing Meta Platforms Inc. for contributing to the youth mental health crisis by knowingly designing features on Instagram and Facebook that addict children to the platforms.
The drugmaker accused 11 companies of importing products that they say contain tirzepatide, the active ingredient in Mounjaro, while falsely implying that their products are associated with Eli Lilly or approved by the FDA.
Indiana and Arkansas have filed similar lawsuits, while the U.S. Supreme Court prepares to decide whether state attempts to regulate social media platforms such as Facebook, X and TikTok violate the Constitution.
Fundraising software company Blackbaud agreed Thursday to pay $49.5 million to settle claims brought by the attorneys general of 49 states and Washington, D.C., related to a 2020 data breach that exposed sensitive information from 13,000 not-for-profits.
U.S. District Judge Hector Gonzalez said the plaintiff failed to prove that a reasonable customer would be misled by the ads.
The decision represents a rare case of a judge overturning a jury verdict and is a major win for Lilly, which argued strenuously that its Emgality drug is substantially different than Anjovy, a drug sold by competitor Teva Pharmaceuticals.
The lawsuit seeks to prevent Inari “from continuing its brazen efforts to steal Corteva’s groundbreaking, patent-protected work,” according to the complaint.
The labor department looked into potential discrimination by the federal contractor at its Indianapolis facility as a part of a routine investigation, federal officials said.
The long-awaited move seeks to bar the company from allegedly abusing its powers to raise prices for shoppers and levy high fees against businesses that sell on its platform.
Lilly is suing medical spas, wellness centers and compounding pharmacies in various U.S. states that sell unapproved versions of its blockbuster diabetes drug, which is frequently used off-label for weight loss.
John Rust, chairman of the board of Seymour-based egg producer Rose Acre Farms, argues that a 2021 state election law “creates a cycle of voter disenfranchisement.”
The Indiana Economic Development Corp., the state’s job-creation agency, intervened on behalf of the city in an effort to get the lawsuit dismissed.
North Dakota-based restaurant company BT Brands, which dropped its lawsuit against Noble Roman’s late last week, said it will continue in its efforts to effect changes to the Noble Roman’s board of directors.
The lawsuit was filed in 2021 over the tech giant’s alleged monopolistic control of app distribution for the software that runs most of the world’s cellphones.
Food ads have long made their subjects look bigger, juicier and crispier. Some consumers say those mouthwatering ads cross the line into deception, and that’s leading to a growing number of lawsuits.
